fda bpc-157 not approved human use warning unapproved peptide safety risks new drug The FDA has issued clear signals Hot-button peptides like BPC-157 and

Epithalon vs

Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration

No validated dosing, pharmacokinetics, or long-term safety There is no human pharmacokinetic data for injectable BPC-157: How long it lasts in the body What tissues it reaches Whether it accumulates How it is metabolized or excreted Long-term risks cannot be assessed without such information

NNMT catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM, the universal methyl donor in cells) to nicotinamide (a form of vitamin B3 and a precursor for NAD+ synthesis), producing 1-methylnicotinamide and S-adenosylhomocysteine (SAH)

But if the BUD is only 30 days, you can only use four doses before expiration, wasting roughly a third of the vial